← Back to Search

Text Messaging for Physical Inactivity in Middle Age (MASTERY Trial)

Phase 1

Recruiting

Led By Jeff C Huffman, MD

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 weeks; 12 weeks

Awards & highlights

MASTERY Trial Summary

This trial is testing whether a text message intervention can help middle-aged adults be more physically active. The intervention involves weekly text message sessions for 12 weeks.

Who is the study for?

This trial is for adults aged 45-64 who are not very active, doing less than 150 minutes of moderate to vigorous physical activity per week. They must be able to increase their physical activity and have a phone that can send texts. People with heart disease, mobility issues, or involvement in other well-being programs cannot join.Check my eligibility

What is being tested?

The study tests a text messaging program called MASTERY designed to boost physical activity over 12 weeks through weekly interactive texts about wellness activities, goal setting, and stress reduction techniques specific to midlife challenges.See study design

What are the potential side effects?

Since this intervention involves lifestyle changes rather than medication, side effects may include muscle soreness or fatigue due to increased physical activity. However, these are typically mild and decrease as fitness improves.

MASTERY Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 weeks; 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 weeks; 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks; 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Moderate-Vigorous Physical Activity [MVPA]

Secondary outcome measures

Change in anxiety (Hospital Anxiety and Depression Scale anxiety subscale [HADS-A])

Change in blood pressure (millimeters of mercury)

Change in body mass index (in kilograms per square meter)

+21 more

MASTERY Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: MASTERY InterventionExperimental Treatment1 Intervention

Participants will complete a positive psychology activity, work towards a physical activity goal, and use a stress reduction technique, then will complete weekly text message sessions. In the first six weeks, participants will review the activities they performed the prior week, be introduced to new material, choose activities to perform that week, and set a new physical activity goal during the text message sessions. In the final 6 weeks, participants will review progress towards prior goals, set new physical activity goals, and choose positive psychology and stress reduction skills to use that week. Finally, over the course of the program participants will complete three brief calls with a study trainer to discuss progress.

Group II: Attentional controlActive Control1 Intervention

Participants will receive the same physical activity component noted in MASTERY along with added messages providing education and guidance about physical activity, from our past work. Control participants will not receive PP or midlife-related content.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

MASTERY

2019

N/A

~20

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor

2,928 Previous Clinical Trials

13,198,275 Total Patients Enrolled

Jeff C Huffman, MDPrincipal InvestigatorMassachusetts General Hospital

15 Previous Clinical Trials

1,117 Total Patients Enrolled

Media Library

MASTERY Clinical Trial Eligibility Overview. Trial Name: NCT04849052 — Phase 1

Middle Age Research Study Groups: Attentional control, MASTERY Intervention

Middle Age Clinical Trial 2023: MASTERY Highlights & Side Effects. Trial Name: NCT04849052 — Phase 1

MASTERY 2023 Treatment Timeline for Medical Study. Trial Name: NCT04849052 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To whom does this research opportunity extend?

"For eligibility, potential participants must be middle-aged and have an age range between 45 to 64 years old. The trial is expecting to recruit 80 patients in total."

Answered by AI

Is there availability to participate in this research endeavor?

"This investigation, which was initially advertised on September 16th 2021, is still actively seeking participants according to clinicaltrials.gov's records. The most recent update was made on March 16th 2022."

Answered by AI